|
|
???tair.name??? >
???browser.page.title.author???
|
"kao j h"???jsp.browse.items-by-author.description???
Showing items 1456-1480 of 1534 (62 Page(s) Totally) << < 53 54 55 56 57 58 59 60 61 62 > >> View [10|25|50] records per page
| 國立臺灣大學 |
2015 |
Treating Immune-tolerant Hepatitis B
|
Tseng, T-C; Kao, J-H; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study
|
Huang, Y. -W.; Wang, T. -C.; Yang, S. -S.; Lin, S. -Y.; Fu, S. -C.; Hu, J. -T.; Liu, C. -J.; Kao, J. -H.; Chen, D. -S.; 陳定信; 高嘉宏; 劉俊人 |
| 臺大學術典藏 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Sheng W.-H.; Liu C.-H.; HSIN-YUN SUN; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 國立交通大學 |
2014-12-08T15:15:23Z |
Finding point correspondence using local similarity and global constraint under insignificant scaling and roll
|
Kao, J. -H.; Chuang, J. -H.; Hsieh, M. -L. |
| 國立臺灣大學 |
2014 |
THE CRISPR/Cas9 SYSTEM FACILITATES ELIMINATION OF THE PERSISTENT INTRAHEPATIC HBV GENOMES IN VIVO
|
Yang, H. -C.; Lin, S. -R.; Liu, C. -J.; Kao, J. -H.; Chen, D. -S.; Chen, P. -J.; 陳定信; 高嘉宏; 楊宏志; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
LOWER RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN NON-DIABETIC CHRONIC HEPATITIS B PATIENTS WITH NEW ONSET HYPERLIPIDEMIA: A NATIONWIDE COHORT STUDY
|
Huang, Y. -W.; Wang, T. -C.; Hsu, C. -K.; Chen, D. -S.; Hu, J. -T.; Kao, J. -H.; Yang, S. -S.; 陳定信; 高嘉宏 |
| 國立臺灣大學 |
2014 |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Chen, B. -B.; Hsu, C. -Y.; Yu, C. -W.; Kao, J. -H.; Lee, H. -S.; Liang, P. -C.; Wei, S. -Y.; Hwang, R. -M.; Shih, T. T. -F.; 高嘉宏; 施庭芳; 許昭禹; 李宣書; 游治維 |
| 國立臺灣大學 |
2014 |
SPONTANEOUS SEROCLEARANCE OF HBsAg IN HEPATITIS B VIRUS/HEPATITIS C VIRUS DUALLY INFECTED PATIENTS: A 10-YEAR FOLLOW-UP
|
Liu, C. -J.; Wu, L. -W.; Tseng, T. -C.; Yang, W. -T.; Su, T. -H.; Yang, H. -C.; Liu, C. -H.; Kao, J. -H.; Chen, D. -S.; Chen, P. -J. |
| 臺大學術典藏 |
2014 |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F. |
| 臺大學術典藏 |
2014 |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee H.-S.; PO-CHIN LIANG; Wei S.-Y.; Shih T.T.F. |
| 臺大學術典藏 |
2014 |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
YEN-HENG LIN; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Shih T.T.F. |
| 臺大學術典藏 |
2014 |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Yu C.-W.; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; TIFFANY TING-FANG SHIH; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Lin Y.-H. |
| 國立政治大學 |
2013-06 |
Hepatitis B viral factors and treatment responses in chronic hepatitis B
|
Lin, Chih-Lin; 林志陵; Kao, J.-H. |
| 國立政治大學 |
2013-06 |
Hepatitis B virus genotypes: Clinical relevance and therapeutic implications
|
Lin, Chih-Lin; 林志陵; Kao, J.-H. |
| 國立政治大學 |
2013-01 |
Risk stratification for hepatitis B virus related hepatocellular carcinoma
|
Lin, Chih-Lin;Kao, J.-H.; 林志陵 |
| 國立臺灣大學 |
2013 |
ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT
|
Liu, C. -J.; Wang, C. -C.; Yang, S. -S.; Su, C. -W.; Liao, L. -Y.; Lee, T. -H.; Chuang, W. -L.; Chen, C. -L.; Chien, R. -N.; Peng, C. -Y.; Lee, C. -M.; Lee, Y. -F.; Kao, J. -H.; Chen, P. -J.; Chen, D. -S.; 劉俊人 |
| 國立臺灣大學 |
2013 |
ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
|
Buti, M.; Flisiak, R.; Rasenack, J.; Davis, G.; Alberti, A.; Goeser, T.; Stanciu, C.; Chuang, W. -L.; Tabak, F.; Kao, J. -H.; Streinu-Cercel, A.; Hofstetter, G.; Wang, J.; Avila, C.; Orsenigo, R.; 高嘉宏 |
| 國立臺灣大學 |
2013 |
Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan
|
Hsu, C-S; Kao, J-H; Chao, Y-C; Lin, H. H.; Fan, Y-C; Huang, C-J; Tsai, P-S; 高嘉宏 |
| 臺大學術典藏 |
2013 |
A Physiology-Based Seizure Detection System for Multichannel EEG
|
Shen, C.-P.;Liu, S.-T.;Zhou, W.-Z.;Lin, F.-S.;Lam, A.Y.-Y.;Sung, H.-Y.;Chen, W.;Lin, J.-W.;Chiu, M.-J.;Pan, M.-K.;Kao, J.-H.;Wu, J.-M.;Lai, F.; Shen, C.-P.; Liu, S.-T.; Zhou, W.-Z.; Lin, F.-S.; Lam, A.Y.-Y.; Sung, H.-Y.; Chen, W.; Lin, J.-W.; Chiu, M.-J.; Pan, M.-K.; Kao, J.-H.; Wu, J.-M.; Lai, F.; FEI-PEI LAI |
| 臺大學術典藏 |
2013 |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; Kao J.-H.; SHU-CHEN WEI; Lin S.-C.; Huang Y.-W. |
| 中國醫藥大學 |
2012-07 |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
(Hsu, C-S);(Hsu S–J);陳弘家;(Liu, C-H);(Jeng J);(Liu, C-J);(Chen, P-J);(Chen, D-S);(Kao, J-H)* |
| 國立臺灣大學 |
2012 |
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
|
Hsu, C. -S.; Liu, C. -H.; Wang, C. -C.; Tseng, T. -C.; Liu, C. -J.; Chen, C. -L.; Chen, P. -J.; Chen, D. -S.; Kao, J. -H.; 陳定信; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP
|
Liu, C. -J.; Chuang, W. -L.; Lee, C. -M.; Yu, M. -L.; Lu, S. -N.; Wu, S. -S.; Liao, L. -Y.; Chen, C. -L.; Kuo, H. -T.; Chao, Y. -C.; Tung, S. -Y.; Yang, S. -S.; Kao, J. -H.; Liu, C. -H.; Su, W. -W.; Lin, C. -L.; Chen, P. -J.; Chen, D. -S.; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR
|
Alberti, A.; Chuang, W. -L.; Flisiak, R.; Mazzella, G.; Horban, A.; Goeser, T.; Calistru, P.; Buti, M.; Davis, G.; Gong, Y.; Avila, C.; Kao, J. -H.; 高嘉宏 |
Showing items 1456-1480 of 1534 (62 Page(s) Totally) << < 53 54 55 56 57 58 59 60 61 62 > >> View [10|25|50] records per page
|